Equities

Eyebright Medical Technology Beijing Co Ltd

688050:SHH

Eyebright Medical Technology Beijing Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)95.55
  • Today's Change-3.96 / -3.98%
  • Shares traded2.17m
  • 1 Year change-8.10%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Eyebright Medical Technology Beijing Co Ltd is a China-based company principally involved in the research, development, manufacturing and sales of ophthalmic medical devices. Its main products include ophthalmic surgery and optometry. Surgical products mainly include intraocular lens, capsular tension ring, intraocular lens implantation system, ophthalmic viscoelastic agent, various types of ophthalmic microsurgical instruments and ophthalmic scalpels, and optometry products include corneal orthopaedics (night-wear type), hard contact lens (daily-wear type) and tear test paper, among others. The Company conducts its businesses in domestic and overseas markets.

  • Revenue in CNY (TTM)1.36bn
  • Net income in CNY369.60m
  • Incorporated2010
  • Employees2.07k
  • Location
    Eyebright Medical Technology Beijing Co LtdBuilding 12#12 Changsheng Road, Changping RoadBEIJING 102200ChinaCHN
  • Phone+86 1 089748322
  • Fax+86 1 089747942
  • Websitehttp://www.ebmedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sansure Biotech Inc1.41bn259.42m13.37bn2.01k51.311.82--9.500.44750.44752.4412.620.16670.8782.03701,473.702.5226.742.7930.9776.4367.4715.1242.017.45--0.058322.40-84.3927.12-81.22121.8964.08--
Micro-Tech Nanjing Co Ltd2.68bn550.49m14.03bn2.40k25.413.76--5.242.942.9414.3019.860.61181.656.801,114,222.0012.8710.7415.2612.8266.0463.0421.0419.373.99--0.018335.4321.7821.2046.9920.3239.33--
Shanghai Haohai Biological Tech Co Ltd2.75bn430.21m14.30bn2.16k36.542.83--5.201.861.8611.8924.070.38331.607.601,272,966.005.604.846.605.5068.9772.0414.6116.363.71--0.069736.8624.5911.24130.580.076211.96--
Beijing Balance Medical Technolgy Co Ltd405.57m103.55m16.49bn473.00159.3414.07--40.650.75310.75312.968.530.31831.094.94857,444.607.148.067.468.4088.3189.4122.4230.028.22--0.009169.1925.5727.3521.0928.10125.94--
iRay Technology Co Ltd1.82bn564.72m17.08bn1.66k31.983.72--9.373.743.7412.1432.150.25441.032.561,097,588.007.8112.078.4813.8653.9255.5930.7134.514.23--0.397231.5220.3133.51-5.2758.58107.96--
Eyebright Medical Tchnlgy Beijing Co Ltd1.36bn369.60m18.86bn2.07k50.968.09--13.891.951.957.1712.290.45992.404.64654,939.8011.739.9913.2911.1665.5881.2925.5034.663.7641.180.190419.9164.1449.5930.6371.8038.83--
MGI Tech Co Ltd2.58bn-873.08m21.28bn2.87k--2.66--8.26-2.12-2.126.2619.210.24670.77452.87898,663.20-8.40---9.62--59.99---34.04--3.99--0.0766---31.19---129.98------
Data as of Nov 15 2024. Currency figures normalised to Eyebright Medical Technology Beijing Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

21.19%Per cent of shares held by top holders
HolderShares% Held
Harvest Fund Management Co., Ltd.as of 30 Jun 202414.67m7.75%
E Fund Management Co., Ltd.as of 30 Sep 20244.20m2.22%
China Universal Asset Management Co., Ltd.as of 30 Jun 20243.85m2.03%
Hwabao WP Fund Management Co., Ltd.as of 31 Mar 20243.75m1.98%
China Southern Asset Management Co., Ltd.as of 30 Jun 20243.15m1.67%
Hongde Fund Management Co., Ltd.as of 30 Jun 20242.79m1.47%
Aegon-Industrial Fund Management Co., Ltd.as of 30 Jun 20242.07m1.09%
Bosera Asset Management Co., Ltd.as of 30 Jun 20242.06m1.09%
Fullgoal Fund Management Co., Ltd.as of 30 Jun 20242.03m1.07%
Norges Bank Investment Managementas of 30 Jun 20241.55m0.82%
More ▼
Data from 30 Jun 2024 - 29 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.